WO2005023979A3 - Isolated s. mansoni nucleic acid molecules and uses thereof - Google Patents

Isolated s. mansoni nucleic acid molecules and uses thereof Download PDF

Info

Publication number
WO2005023979A3
WO2005023979A3 PCT/BR2004/000170 BR2004000170W WO2005023979A3 WO 2005023979 A3 WO2005023979 A3 WO 2005023979A3 BR 2004000170 W BR2004000170 W BR 2004000170W WO 2005023979 A3 WO2005023979 A3 WO 2005023979A3
Authority
WO
WIPO (PCT)
Prior art keywords
mansoni
nucleic acid
acid molecules
isolated
immunoprophylactic
Prior art date
Application number
PCT/BR2004/000170
Other languages
French (fr)
Other versions
WO2005023979A2 (en
Inventor
Sergio Verjovski-Almeida
Luciana C C Leite
Leonardo P Farias
Patricia A Miyasato
Toshie Kawano
Ricardo Demarco
Julio Cesar Levano Garcia
Elizabeth A L Martins
Paulo L Ho
Ana L T O Nascimento
Emmanuel Dias-Neto
Joao C Setubal
Carlos F M Menck
Alda M B N Madeira
Vanderlei Rodrigues
Cybele Gargioni
Original Assignee
Fundacao De Amparo A Pesquisa
Sergio Verjovski-Almeida
Luciana C C Leite
Leonardo P Farias
Patricia A Miyasato
Toshie Kawano
Ricardo Demarco
Julio Cesar Levano Garcia
Elizabeth A L Martins
Paulo L Ho
Ana L T O Nascimento
Emmanuel Dias-Neto
Joao C Setubal
Carlos F M Menck
Alda M B N Madeira
Vanderlei Rodrigues
Cybele Gargioni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao De Amparo A Pesquisa, Sergio Verjovski-Almeida, Luciana C C Leite, Leonardo P Farias, Patricia A Miyasato, Toshie Kawano, Ricardo Demarco, Julio Cesar Levano Garcia, Elizabeth A L Martins, Paulo L Ho, Ana L T O Nascimento, Emmanuel Dias-Neto, Joao C Setubal, Carlos F M Menck, Alda M B N Madeira, Vanderlei Rodrigues, Cybele Gargioni filed Critical Fundacao De Amparo A Pesquisa
Priority to BRPI0413944-5A priority Critical patent/BRPI0413944A/en
Publication of WO2005023979A2 publication Critical patent/WO2005023979A2/en
Publication of WO2005023979A3 publication Critical patent/WO2005023979A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to S. Mansoni proteins, and the nucleic acid molecules which encode them. Various uses are described, including immunoprophylactic, diagnostic and therapeutic methods.
PCT/BR2004/000170 2003-09-11 2004-09-10 Isolated s. mansoni nucleic acid molecules and uses thereof WO2005023979A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0413944-5A BRPI0413944A (en) 2003-09-11 2004-09-10 isolated nucleic acid molecules of s. mansoni and use of these

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50227703P 2003-09-11 2003-09-11
US60/502,277 2003-09-11

Publications (2)

Publication Number Publication Date
WO2005023979A2 WO2005023979A2 (en) 2005-03-17
WO2005023979A3 true WO2005023979A3 (en) 2005-07-07

Family

ID=34273087

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2004/000170 WO2005023979A2 (en) 2003-09-11 2004-09-10 Isolated s. mansoni nucleic acid molecules and uses thereof

Country Status (2)

Country Link
BR (1) BRPI0413944A (en)
WO (1) WO2005023979A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013010926A2 (en) * 2010-11-01 2016-08-23 Univ Technology Sidney immunomodulatory agents and their uses
US8734807B1 (en) 2013-04-06 2014-05-27 Gabriel Langlois-Rahme Preventing and curing Schistosomiasis mansoni by inhibiting Trk receptors on female Schistosoma
CN111321145B (en) * 2020-03-09 2022-12-20 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) SiRNA of schistosoma japonicum PHB1 and PHB2 genes and application thereof
CN112300259A (en) * 2020-11-06 2021-02-02 中国科学院南海海洋研究所 Autophagy protein beclin-1 and coding gene and application thereof
CN115820683B (en) * 2022-09-28 2024-04-05 西南大学 Silkworm Cyp9a20 gene and application thereof
CN116874598B (en) * 2023-07-11 2024-10-01 广西大学 Schistosoma japonicum BMP monoclonal antibody and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VALADAO ET AL.: "Y-box binding protein from Schistosoma mansoni: interaction with DNA and RNA", MOLECULAR AND BIOLOGICAL PARASITOLOGY, vol. 125, no. 1-2, November 2002 (2002-11-01) - December 2002 (2002-12-01), pages 47 - 57 *

Also Published As

Publication number Publication date
WO2005023979A2 (en) 2005-03-17
BRPI0413944A (en) 2006-12-26

Similar Documents

Publication Publication Date Title
WO2005014035A3 (en) Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
WO2001092308A3 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
WO2002002624A3 (en) B7-like molecules and uses thereof
WO2002008285A3 (en) Il-17 molecules and uses thereof
WO2002024891A3 (en) B7-like molecules and uses thereof
WO2005005599A3 (en) Modulation of c-reactive protein expression
WO2002020762A8 (en) Tnf receptor-like molecules and uses thereof
WO2005019264A3 (en) Human lxr alpha variants
WO2000053776A3 (en) Human kallikrein-like genes
WO2004009024A3 (en) Modulation of protein kinase c-iota expression
WO2003016551A3 (en) Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
WO2006043060A3 (en) Mam domain containing protein
WO2001059120A3 (en) Il-17 like molecules and uses thereof
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2004089982A3 (en) April variants and methods thereof
WO2002044366A3 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
WO2004076613A3 (en) Human nucleic acid sequences from carcinomas of the bladder
WO2004056983A3 (en) Metalloprotease proteins
WO2004053117A3 (en) Serine protease
WO2006020824A3 (en) Diagnosis and treatment of kawasaki disease and coronavirus infection
AU2002337248A1 (en) Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses
WO2002044379A3 (en) Transforming growth factor-beta-related molecules and uses thereof
WO2002062845A3 (en) Adhesion molecules
WO2004101618A3 (en) Progestin-yol002c-cgi-45 receptor-related proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
ENP Entry into the national phase

Ref document number: PI0413944

Country of ref document: BR